Some patients may require levothyroxine dose reductions as they lose weight, while the relationship is not always linear or predictable
This medication belongs to a class known as GLP-1 receptor agonists, which operate by mimicking the glucagon-like peptide-1 hormone responsible for regulating appetite and food intake
Gradual dose escalation and monitored weight loss form the cornerstone of risk reduction
This information proves invaluable for identifying triggers and guiding treatment adjustments with your healthcare team
In eukaryotes, GSH-Px enzymes catalyze the reduction of organic hydroperoxides and H 2 O 2 into their corresponding alcohols (or water, in the case of H 2 O 2 ) using GSH as an electron donor [15, 16]
BJOG: An International Journal of Obstetrics & Gynaecology , 111(11), 1204-1212